ArticleCancer research communications2022

Targeting the Ezrin Adaptor Protein Sensitizes Metastatic Breast Cancer Cells to Chemotherapy and Reduces Neoadjuvant Therapy-induced Metastasis.

Victoria Hoskin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.